Age | Median (Y) | Range |
---|---|---|
10 | 2.2 – 18 | |
Sex | Male (%) | Female (%) |
116 (69.9) | 50 (30.1) | |
Race | White (%) | Black (%) |
138(83.1) | 28 (16.9) | |
Symptoms time | Median (M) | Range (M) |
6 | 1–12 | |
Clinical stage | Number(%) | |
I | 19 (11.7) | |
II | 60 (36.1) | |
III | 55 (33.1) | |
IV | 32 (19.1) | |
Histology | Number (%) | |
Sclerosis nodular | 80(48.1) | |
Mixed celullarity | 57(34.3) | |
Lymphocitic depletion | 26(15.6) | |
Predominant lymphocitic | 3 (1.8) | |
Symptoms B | Number (%) | |
Present | 112 (67.5%) | |
Absent | 54 (32.5%) |